Jazz Pharmaceuticals's total assets for Q2 2026 were $11.08B, a decrease of -6.57% from the previous quarter. MX:JAZZN total liabilities were $6.28B for the fiscal quarter, a -14.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.